Omi have signed a LOI with an undisclosed distribution customer who may pay them for their auto retract syringe if certain guidelines are met. This would appear to be for the Non RTF syringes . As such it does not imho immediatly negativly impact UNI which would seem to have the RTF market tied up. I for one have always considered that the non RTF market would be more competitive than the RTF . OMI are also complaining about an undisclosed competitor basically staking their customers could be UNI i suppose. I could not find the announcement on the OMI website but on COMSEC and presumably also on the ASX . Meanwhile they are trying to raise money to devlop other product
UNI Price at posting:
33.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)